Clinical Trial Update: Long-term Safety of Protopic in Atopic Eczema [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update summarizes long-term safety findings for Protopic (tacrolimus) in atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Protopic (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Dermatitis, Atopic, Eczema, Atopic | Phase 3 | Status: COMPLETED